Search
for
Sort by
Research 811–840 of 819
- Androgens’ Effects across the Lifespan in Men and Animal Models
- Sex Differences in Opioid-Mediated Effects: Role of Androgens
- Dihydrotestosterone and 5α-Reductase
- Antiepileptogenic effects of trilostane in the kainic acid model of temporal lobe epilepsy
- Comparative Study of Some Potential Paracrine Factors Produced by Normal and Androgenetic Alopecia Hair Follicles
- CSI on steroids
- Symptomatic hypercalcemia and scarring alopecia as presenting features of sarcoidosis
- Androgenetic Alopecia: Pathophysiological Aspects in Man and Animals
- Development of Hair Keratin Protein to Accelerate Oral Mucosal Regeneration
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Low-Dose Dimethyl Sulfoxide (DMSO) Suppresses Androgen Receptor (AR) and Its Splice Variant AR-V7 in Castration-Resistant Prostate Cancer (CRPC) Cells
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Redefining hormone resistance in prostate cancer
- Endocrinology of the Aging Prostate: Current Concepts
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- HSD3B1 Genotypes Conferring Adrenal-Restrictive and Adrenal-Permissive Phenotypes in Prostate Cancer and Beyond
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Editorial: Androgen-dependent diseases and their treatment
- New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
- Highlights of This Issue
- Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
- Alternative androgen pathways
- Hormone Blocking Anticancer Drugs
- Therapeutic Strategies to Target the Androgen Receptor
- Unravelling the link between insulin resistance and androgen excess
- Novel Vitamin D Receptor Mutations in Hereditary Vitamin D Resistant Rickets in Chinese